Filing Details
- Accession Number:
- 0001567619-22-008802
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-04-21 16:22:23
- Reporting Period:
- 2021-02-18
- Accepted Time:
- 2022-04-21 16:22:23
- Original Submission Date:
- 2021-02-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1829802 | Sensei Biotherapeutics Inc. | SNSE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1843594 | James Peyer | C/O Sensei Biotherapeutics, Inc. 1405 Research Blvd. Suite 125 Rockville MD 20850 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-18 | 752 | $19.75 | 4,690,905 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
Footnotes
- This Form 4 is being amended to correct the number of shares purchased. The original Form 4 filed on February 19, 2021, overstated the number of shares purchased.
- These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian").The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
Billionaire Hedge Funds
